Benchmarking Multi-turn Medical Diagnosis: Hold, Lure, and Self-Correction
Organizations: The University of Texas at Austin · New York University · The University of Texas Southwestern Medical Center · University of North Carolina at Chapel Hill ·
Abstract
Large language models (LLMs) achieve high accuracy in medical diagnosis when all clinical information is provided in a single turn, yet how they behave under multi-turn evidence accumulation closer to real clinical reasoning remains unexplored. We introduce MINT (Medical Incremental N-Turn Benchmark), a high-fidelity, multi-turn medical diagnosis benchmark comprising 1,035 cases with clinically labeled evidence shards, controlled turn granularity, and information-preserving decomposition. Through systematic evaluation of 11 LLMs on MINT, we uncover three persistent behavioral patterns that significantly impact diagnostic decisions: (1) intent to answer, models rush to answer before sufficient evidence has been observed, with over 55% of answers committed within the first two turns; (2) self-correction, incorrect-to-correct answer revisions occur at up to 10.6 times the rate of correct-to-incorrect flips, revealing a latent capacity for self-correction that premature commitment forecloses; and (3) strong lures, clinically salient information such as laboratory results trigger premature answering even when models are explicitly instructed to wait. We translate these findings into clinically actionable guidance: deferring the diagnostic question to later turns reduces premature answering and improves accuracy at the first point of commitment by up to 62.6%, while reserving salient clinical evidence for later turns prevents a catastrophic accuracy drop of up to 23.3% caused by premature commitment. Our work provides both a controlled evaluation framework and concrete recommendations for improving the reliability of LLMs in multi-turn medical diagnosis.
Figures & tables
| MedQA | Derm-Public | Derm-Private | MedBullets | MedMCQA | |||||||||||||||||||||||||||||||
| Single-turn | Multi-turn | Single-turn | Multi-turn | Single-turn | Multi-turn | Single-turn | Multi-turn | Single-turn | Multi-turn | ||||||||||||||||||||||||||
| Q-First | Q-Last | Q-First | Q-Last | Q-First | Q-Last | Q-First | Q-Last | Q-First | Q-Last | ||||||||||||||||||||||||||
| Model | Full | Conc. | Ini. | Final | Abs. | Ans. | Abs. | Full | Conc. | Ini. | Final | Abs. | Ans. | Abs. | Full | Conc. | Ini. | Final | Abs. | Ans. | Abs. | Full | Conc. | Ini. | Final | Abs. | Ans. | Abs. | Full | Conc. | Ini. | Final | Abs. | Ans. | Abs. |
| Open-Source General LLMs | |||||||||||||||||||||||||||||||||||
| Qwen2.5-3B | 53.3 | 51.3 | 36.2 | 29.8 | 27.2 | 50.2 | 0.0 | 64.0 | 69.0 | 39.1 | 28.1 | 36.0 | 60.0 | 0.0 | 74.8 | 75.8 | 48.0 | 29.9 | 22.2 | 66.7 | 0.0 | 40.3 | 41.9 | 33.3 | 26.7 | 27.4 | 40.3 | 0.0 | 73.0 | 70.7 | 47.5 | 44.5 | 21.3 | 68.4 | 0.0 |
| Qwen3-4B | 63.8 | 65.2 | 53.0 | 58.8 | 8.5 | 58.9 | 0.2 | 82.0 | 79.0 | 67.0 | 74.0 | 0.0 | 79.0 | 0.0 | 87.9 | 84.8 | 58.8 | 73.2 | 2.0 | 86.9 | 0.0 | 48.4 | 48.4 | 42.9 | 44.6 | 9.7 | 56.5 | 0.0 | 84.1 | 80.6 | 58.7 | 71.9 | 4.0 | 77.3 | 0.0 |
| Model | Avg Ini. Turn | Abs | Ini. | Full | |
| MedGemma-27B | 46.7 | 77.3 | 86.6 | -9.3 | |
| Claude Sonnet 4.6 | 22.0 | 90.1 | 96.5 | -6.4 | |
| Qwen3-4B | 7.1 | 56.8 | 77.5 | -20.7 | |
| o4-mini | 2.2 | 82.0 | 96.1 | -14.1 | |
| GPT-5-mini | 1.6 | 80.4 | 96.1 | -15.7 | |
| GPT-OSS-20B | 1.1 | 67.8 | 90.0 | -22.2 |
| MedQA | Derm-Public | Derm-Private | MedBullets | MedMCQA | |||||||||||||||||||||
| # Turns | Q.F | FR | T2F | F2T | Q.L | Q.F | FR | T2F | F2T | Q.L | Q.F | FR | T2F | F2T | Q.L | Q.F | FR | T2F | F2T | Q.L | Q.F | FR | T2F | F2T | Q.L |
| 4 | 80.7 | 20.7 | 0.8 | 16.7 | 96.5 | 82.9 | 15.0 | 1.2 | 11.2 | 92.7 | 90.6 | 10.6 | 0.0 | 9.4 | 100.0 | 63.8 | 30.9 | 3.6 | 25.5 | 80.3 | 85.0 | 17.2 | 1.3 | 14.6 | 98.1 |
| 8 | 76.3 | 27.0 | 1.5 | 20.3 | 94.9 | 79.3 | 22.0 | 2.4 | 17.1 | 95.1 | 90.1 | 13.6 | 0.0 | 8.6 | 100.0 | 55.9 | 40.7 | 3.4 | 28.8 | 78.3 | 84.1 | 19.2 | 0.6 | 14.7 | 98.1 |
| 12 | 77.2 | 28.9 | 1.6 | 19.8 | 93.8 | 83.1 | 16.9 | 1.2 | 10.8 | 92.8 | 84.7 | 17.6 | 0.0 | 15.3 | 100.0 | 60.0 | 34.5 | 1.8 | 20.0 | 76.4 | 86.1 | 20.5 | 2.0 | 12.6 | 98.0 |
| 16 | 77.5 | 27.3 | 1.1 | 19.2 | 95.8 | 80.7 | 21.7 | 2.4 | 14.5 | 94.0 | 83.5 | 18.8 | 0.0 | 15.3 | 100.0 | 59.3 | 39.0 | 3.4 | 23.7 | 79.7 | 87.3 | 18.4 | 1.3 | 11.4 | 98.1 |
| MedQA | Derm-Public | Derm-Private | MedBullets | MedMCQA | ||||||||||||||||
| Model | FR | T2F | F2T | RR | FR | T2F | F2T | RR | FR | T2F | F2T | RR | FR | T2F | F2T | RR | FR | T2F | F2T | RR |
| Open-Source General LLMs | ||||||||||||||||||||
| Qwen2.5-3B | 52.2 | 16.0 | 9.6 | 0.60 | 53.1 | 20.3 | 9.4 | 0.46 | 50.7 | 22.1 | 3.9 | 0.18 | 46.7 | 17.8 | 11.1 | 0.62 | 45.3 | 14.6 | 11.7 | 0.80 |
| Qwen3-4B | 27.0 | 4.5 | 10.4 | 2.31 | 13.0 | 0.0 | 7.0 | N/A | 19.6 | 0.0 | 14.4 | N/A | 17.9 | 1.8 | 3.6 | 2.00 | 25.8 | 1.8 | 15.0 | 8.33 |
| OLMo-2-7B | 93.0 | 19.2 | 17.6 | 0.92 | 87.0 | 19.0 | 23.0 | 1.21 | 94.9 | 19.2 | 26.3 | 1.37 | 93.6 | 6.5 | 11.3 | 1.74 | 92.0 | 16.7 | 24.1 | 1.44 |
| GPT-OSS-20B | 52.3 | 3.5 | 30.9 | 8.83 | 37.0 | 2.0 | 24.0 | 12.00 | 40.4 | 1.0 | 31.3 | 31.30 | 54.8 | 3.2 | 27.4 | 8.56 | 35.8 | 1.2 | 19.7 | 16.42 |
Appendix figures & tables7 assets
Supplementary material from the paper’s appendix.
Appendix
| MINT | N | Mean/Turn | Median/Turn | Len./Case | Lab/Shard |
| MedQA ( Johri et al., 2025 ) | 600 | 9.92 | 10 | 128.39 | 249 (41.5%) |
| MedMCQA ( Pal et al., 2022 ) | 174 | 8.75 | 8 | 88.98 | 86 (49.4%) |
| Derm-Public ( Johri et al., 2025 ) | 100 | 7.79 | 8 | 155.29 | 8 (8.0%) |
| Derm-Private ( Johri et al., 2025 ) | 99 | 7.75 | 8 | 139.31 | 7 (7.1%) |
| MedBullets ( Chen et al., 2025 ) | 62 | 10.74 | 11 | 169.63 | 20 (32.3%) |
| Overall | 1035 | 9.36 | 9 | 124.63 | 370 (35.7%) |
| Disease | GPT-5-mini | Claude Sonnet 4.6 | Qwen3-4B | MedGemma-27B | ||||||||
| Early | Middle | Late | Early | Middle | Late | Early | Middle | Late | Early | Middle | Late | |
| Cardiovascular System | 63.64 | 90.91 | 90.91 | 45.45 | 63.64 | 63.64 | 54.55 | 63.64 | 63.64 | 27.27 | 36.36 | 27.27 |
| Dermatology | 54.55 | 63.64 | 90.91 | 54.55 | 45.45 | 63.64 | 18.18 | 27.27 | 27.27 | 45.45 | 54.55 | 27.27 |
| Endocrinology | 86.11 | 88.89 | 80.56 | 72.22 | 94.44 | 75.00 | 36.11 | 41.67 | 44.44 | 36.11 | 33.33 | 38.89 |
| Gastrointestinal System | 79.17 | 75.00 | 83.33 | 75.00 | 83.33 | 58.33 | 54.17 | 45.83 | 54.17 | 45.83 | 58.33 | 54.17 |
| Hematology and Oncology | 87.88 | 81.82 | 87.88 | 81.82 | 84.85 | 72.73 | 60.61 | 57.58 | 48.48 | 42.42 | 48.48 | 36.36 |
| Model | Order | Ask Q First | Ask Q Last | |||
| Ini. | Final | Abs. | Final | Abs. | ||
| GPT-5-mini | Early | 76.83 | 95.12 | 0.00 | 96.34 | 0.00 |
| Middle | 77.64 | 94.31 | 0.40 | 95.93 | 0.40 | |
| Late | 77.11 | 96.79 | 0.40 | 95.58 | 0.40 | |
| Claude Sonnet 4.6 | Early | 71.54 | 80.89 | 7.23 | 93.50 | 0.40 |
| Middle | 75.61 | 78.46 | 11.65 | 90.24 | 0.00 | |
Clinical Language Model Evaluation
Clinical language model evaluation measures whether AI systems are accurate, safe, fair, and useful across medical tasks and care settings.
See all 395 papers